Colombo I, Koster KL, Holer L, Haefliger S, et al. TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16). Eur J Cancer 2024;201:113588.
PMID: 38377773